Stock listing
BOATS:SPRY ARS Pharmaceuticals, Inc. Stock
US listing (BOATS) of ARS Pharmaceuticals, Inc. · home listing NASDAQ:SPRY
Follow ARS Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SPRY
$4.23 USD +0.21 (+5.2%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SPRY
- Day range
- $4.00 – $4.32 USDOct 19, 2026
- Volume
- 1.51M sharesOct 19, 2026
- Market cap
- $420.7M USDAt the close on Oct 19, 2026 · price × 99.45M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SPRY · Home | $4.23 USD | +0.21 (+5.2%) | 1,508,947 | $4.07 | $4.32 | $4.00 | $4.02 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:SPRY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.23 | +0.21 | +5.2% | $4.07 | $4.32 | $4.00 | 1,508,947 | |
| $4.02 | -0.05 | -1.2% | $4.08 | $4.08 | $3.81 | 2,332,020 | |
| $4.07 | +0.14 | +3.6% | $3.99 | $4.095 | $3.94 | 2,220,029 | |
| $3.93 | -0.12 | -3.0% | $4.01 | $4.095 | $3.885 | 1,728,590 | |
| $4.05 | -0.13 | -3.1% | $4.18 | $4.18 | $3.995 | 1,546,822 | |
| $4.18 | -0.05 | -1.2% | $4.20 | $4.27 | $4.06 | 1,274,277 | |
| $4.23 | -0.33 | -7.2% | $4.53 | $4.555 | $4.20 | 1,258,395 | |
| $4.56 | +0.20 | +4.6% | $4.35 | $4.635 | $4.21 | 1,585,366 | |
| $4.36 | +0.065 | +1.5% | $4.24 | $4.402 | $4.205 | 1,297,800 | |
| $4.295 | +0.005 | +0.1% | $4.31 | $4.31 | $4.08 | 1,219,200 | |
| $4.29 | +0.22 | +5.4% | $4.13 | $4.395 | $4.03 | 1,621,100 | |
| $4.07 | -0.05 | -1.2% | $4.16 | $4.27 | $3.985 | 1,828,500 | |
| $4.12 | -0.19 | -4.4% | $4.35 | $4.395 | $4.11 | 1,971,600 | |
| $4.31 | -0.09 | -2.0% | $4.43 | $4.45 | $4.24 | 1,297,400 | |
| $4.40 | +0.27 | +6.5% | $4.11 | $4.435 | $4.01 | 1,274,700 | |
| $4.13 | +0.05 | +1.2% | $4.06 | $4.19 | $4.00 | 949,800 | |
| $4.08 | -0.07 | -1.7% | $4.18 | $4.18 | $4.02 | 1,035,000 | |
| $4.15 | -0.03 | -0.7% | $4.21 | $4.24 | $4.07 | 1,052,600 | |
| $4.18 | -0.30 | -6.7% | $4.49 | $4.49 | $4.11 | 1,370,300 | |
| $4.48 | +0.13 | +3.0% | $4.40 | $4.57 | $4.36 | 1,268,000 | |
| $4.35 | +0.24 | +5.8% | $4.16 | $4.385 | $4.07 | 1,197,900 | |
| $4.11 | -0.04 | -1.0% | $4.10 | $4.20 | $4.10 | 1,885,800 | |
| $4.15 | -0.015 | -0.4% | $4.26 | $4.30 | $4.12 | 1,870,600 | |
| $4.165 | -0.085 | -2.0% | $4.25 | $4.365 | $4.125 | 1,451,900 | |
| $4.25 | -0.25 | -5.6% | $4.50 | $4.50 | $4.22 | 2,776,000 | |
| $4.50 | -0.26 | -5.5% | $4.80 | $4.90 | $4.455 | 2,165,300 | |
| $4.76 | -0.30 | -5.9% | $5.13 | $5.19 | $4.73 | 2,570,800 | |
| $5.06 | -0.17 | -3.3% | $5.20 | $5.22 | $5.02 | 1,091,300 | |
| $5.23 | -0.16 | -3.0% | $5.35 | $5.38 | $5.215 | 874,500 | |
| $5.39 | -0.23 | -4.1% | $5.515 | $5.535 | $5.305 | 1,086,500 | |
| $5.62 | -0.05 | -0.9% | $5.60 | $5.70 | $5.54 | 849,500 | |
| $5.67 | -0.15 | -2.6% | $5.86 | $5.90 | $5.605 | 1,088,200 | |
| $5.82 | +0.05 | +0.9% | $5.86 | $6.00 | $5.745 | 1,196,700 | |
| $5.77 | -0.23 | -3.8% | $6.08 | $6.08 | $5.74 | 1,358,000 | |
| $6.00 | +0.11 | +1.9% | $5.87 | $6.09 | $5.615 | 1,984,600 | |
| $5.89 | -0.14 | -2.3% | $6.00 | $6.03 | $5.855 | 1,190,300 | |
| $6.03 | 0.00 | 0.0% | $6.03 | $6.12 | $5.89 | 1,190,800 | |
| $6.03 | +0.31 | +5.4% | $5.70 | $6.09 | $5.67 | 1,162,100 | |
| $5.72 | +0.37 | +6.9% | $5.40 | $5.76 | $5.39 | 1,715,834 | |
| $5.35 | -0.155 | -2.8% | $5.40 | $5.46 | $5.20 | 1,936,733 | |
| $5.505 | 0.00 | 0.0% | $5.52 | $5.60 | $5.465 | 1,267,900 | |
| $5.505 | -0.875 | -13.7% | $6.30 | $6.35 | $5.50 | 2,114,100 | |
| $6.38 | +0.08 | +1.3% | $6.42 | $6.58 | $6.35 | 1,212,400 | |
| $6.30 | +0.06 | +1.0% | $6.12 | $6.52 | $6.12 | 1,945,300 | |
| $6.24 | +0.59 | +10.4% | $5.62 | $6.285 | $5.575 | 2,504,800 | |
| $5.65 | -0.45 | -7.4% | $5.10 | $5.84 | $5.00 | 5,046,000 | |
| $6.10 | +0.05 | +0.8% | $6.08 | $6.19 | $5.90 | 1,978,700 | |
| $6.05 | +0.10 | +1.7% | $5.96 | $6.075 | $5.81 | 1,313,900 | |
| $5.95 | +0.04 | +0.7% | $5.98 | $5.98 | $5.80 | 1,351,809 | |
| $5.91 | -0.25 | -4.1% | $6.06 | $6.185 | $5.80 | 1,330,193 | |
| $6.16 | +0.61 | +11.0% | $5.60 | $6.16 | $5.575 | 2,155,800 | |
| $5.55 | +0.19 | +3.5% | $5.38 | $5.60 | $5.38 | 1,264,500 | |
| $5.36 | +0.04 | +0.8% | $5.32 | $5.46 | $5.22 | 2,542,300 | |
| $5.32 | -0.14 | -2.6% | $5.50 | $5.50 | $5.23 | 1,931,400 | |
| $5.46 | +0.33 | +6.4% | $5.08 | $5.485 | $4.91 | 2,143,500 | |
| $5.13 | -0.50 | -8.9% | $5.55 | $5.605 | $5.11 | 2,083,400 | |
| $5.63 | -0.20 | -3.4% | $5.80 | $5.853 | $5.48 | 1,626,700 | |
| $5.83 | +0.16 | +2.8% | $5.60 | $5.85 | $5.35 | 6,438,200 | |
| $5.67 | -0.09 | -1.6% | $5.72 | $6.01 | $5.66 | 1,352,500 | |
| $5.76 | -0.18 | -3.0% | $6.00 | $6.06 | $5.62 | 1,819,900 | |
| $5.94 | -0.06 | -1.0% | $6.00 | $6.22 | $5.76 | 3,484,900 | |
| $6.00 | -0.06 | -1.0% | $6.10 | $6.10 | $5.765 | 2,660,000 | |
| $6.06 | -0.30 | -4.7% | $6.40 | $6.62 | $6.06 | 3,117,400 | |
| $6.36 | -0.08 | -1.2% | $6.40 | $6.49 | $6.155 | 4,881,000 | |
| $6.44 | -0.56 | -8.0% | $7.00 | $7.141 | $6.42 | 2,933,400 |
- Ticker
- BOATS:SPRY
- Asset type
- Stock
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 5, 2026
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
Latest earnings call · Aug 13, 2026
ARS Pharmaceuticals (NASDAQ:SPRY) Q2 2026 Earnings Call
Replay and transcript
Latest deck · May 15, 2026
Investor Presentation (May 2026)
Investor deck · 22 slides
Calls
Replays
ARS Pharmaceuticals (NASDAQ:SPRY) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 4:30 PM ET
Watch TranscriptARS Pharmaceuticals (NASDAQ:SPRY) Q1 2026 Earnings Call
Fri, May 15, 2026 · 8:30 AM ET
Watch TranscriptARS Pharmaceuticals (NASDAQ:SPRY) Q4 2025 Earnings Call
Mon, Mar 09, 2026 · 8:30 AM ET
Watch Transcript
Latest news
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
Oct 5, 2026
Closed $4.29 (+5.4%) on Oct 5, 2026
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Closed $5.65 (-7.4%) on Aug 14, 2026
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
Aug 3, 2026
Closed $5.46 (+6.4%) on Aug 3, 2026
ARS Pharmaceuticals Announces CEO Succession
Jul 7, 2026
Closed $8.10 (-1.1%) on Jul 8, 2026
Decks
Investor Presentation (May 2026)
Investor deck · 22 slides · May 15, 2026
Q4 2025 Earnings Presentation
Earnings · 22 slides · Mar 9, 2026
Investor Presentation (November 2025)
Investor deck · 19 slides · Nov 10, 2025
Q3 2025 Earnings Presentation
Earnings · 10 slides · Nov 10, 2025
ARS Pharmaceuticals, Inc. on 6ix
- News releases
- 26 in the last 12 months · 92 in all · newest Oct 5, 2026 · oldest 2023
- Calls
- 8 calls with a replay · 8 with a transcript · latest Aug 13, 2026
- Decks
- 20 decks · latest May 15, 2026
Where ARS Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SPRY · Home listing | NASDAQ | United States | USD |
| BOATS:SPRY · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about ARS Pharmaceuticals, Inc.